Sudipta Das was 13 when a friend introduced her to cannabis. She struggled with addiction until she met a Catholic sister three years ago. “I was in a very bad state, mentally and physically, when I came to Orsini home where Sr. Merin Lukose treated me with love and care,” said the 23-year-old woman from the northeastern Indian state of Assam. Das is among more than 1,000 substance abuse patients helped by Orsini Care Home, managed by Lukose’s congregation — the Hospitaller Sisters of Mercy — at Bongaigaon, a town in Assam state. Assam is considered the gateway to this region, which tops…
Author: Isla
UAE economy set to grow 5.6% in 2026: Central Bank report Gulf News Source link
Vietnam confirmed on Thursday that top leader To Lam will visit China next week at the invitation of counterpart Xi Jinping, his first foreign trip since becoming president. To Lam, general secretary of the Communist Party of Vietnam, takes an oath as Vietnam’s president during a National Assembly’s session in Hanoi on April 7, 2026, capping his bid to centralise authority in a nation where senior cadres have traditionally governed collectively. Photo: Dang Anh/AFP. The Communist Party boss was elected president — the number two position in Vietnamese politics — by the National Assembly on Tuesday, unifying leadership of the…
Fanny Au Kwan-yi (fifth left), assistant director of performing arts, in the Leisure and Cultural Services Department; and Ma Fung-kwok (fifth right), president of the China Federation of Literary and Art Circles Hong Kong Member Association, are among the guests and artists attending the Chinese Culture Festival 2026 program briefing at the Hong Korg Cultural Centre in Tsim Sha Tsui on Thursday. (ADAM LAM / CHINA DAILY)A high-level Chinese culture festival showcased the highlights and programs available at this year’s event on Thursday.The Chinese Culture Festival 2026, themed “Legends”, will take place from June to September.The festival will explore Chinese…
The pharmaceutical excipients market is a critical component of the global healthcare and pharmaceutical ecosystem. Excipients are inactive substances formulated alongside active pharmaceutical ingredients (APIs) to aid in drug delivery, stability, bioavailability, and patient acceptability. While they do not provide therapeutic effects, excipients play a vital role in ensuring that medications are safe, effective, and easy to administer.From tablets and capsules to injectables and topical formulations, excipients are essential in nearly every pharmaceutical product. With advancements in drug development, especially biologics and personalized medicine, the importance of high-quality and multifunctional excipients continues to grow.Download Sample Report: https://www.cervicornconsulting.com/sample/2453 ________________________________________ Market…
Ofichem has brought its brands – Ofichem BV, Ofipharma BV, Ofimedicine BV, Laboratorium Ofichem BV, Ofichem Uppsala AB, and Avivia BV – together as one family-owned CDMO and pharmaceutical supplier, marking a strategic step in its evolution.From April 1, all business units will operate under the Ofichem trading name. The move brings together Ofichem’s capabilities across drug substance, drug product, and sourcing and distribution into one integrated offering.As Ofichem has grown, its capabilities have been delivered across multiple brands, while at the same time, pharmaceutical and biotech companies are increasingly looking to reduce complexity by working with fewer, more integrated…
The ALS Association has backed the reintroduction of US legislation aimed at extending programs designed to accelerate treatment development for amyotrophic lateral sclerosis. This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here. Login to your account Try before you buy Free 7 day trial access Take a Free…
Stephen Ubl will step down as president and chief executive of the Pharmaceutical Research and Manufacturers of America (PhRMA) at the end of 2026, ending a decade leading one of Washington’s most influential drug industry groups. This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here. Login to your account…
The pharmaceutical market is one of the most critical sectors in the global healthcare ecosystem, responsible for the discovery, development, production, and distribution of medicines that improve and save lives. It includes a wide range of products such as prescription drugs, over-the-counter (OTC) medications, vaccines, biologics, biosimilars, and generic drugs.Driven by scientific innovation, rising healthcare needs, and technological advancements, the pharmaceutical industry continues to evolve rapidly. The increasing burden of chronic diseases, aging populations, and demand for personalized medicine are further shaping the future of this market.Download Sample Report: https://www.cervicornconsulting.com/sample/2457 ________________________________________ Market Size and ForecastAccording to industry insights, the…
Ofichem has announced the consolidation of its brands — Ofichem BV, Ofipharma, Ofimedicine, Labatorium Ofichem, Ofichem Uppsala and Avivia — into one family-owned CDMO and pharmaceutical supplier. Since April 1st, all business units have been operating under the Ofichem trading name. The brand said that the move was in response to pharmaceutical and biotech companies increasingly looking to reduce complexity by working with fewer, more integrated partners that can support them across the lifecycle of their drug. The decision brings together Ofichem’s capabilities across drug substance, drug product and sourcing and distribution into one integrated offering, giving customers a more connected view…